{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:39:59Z","timestamp":1773772799948,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00131","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T23:28:34Z","timestamp":1465342114000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain"],"prefix":"10.3389","volume":"6","author":[{"given":"Karin S.","family":"Coyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"LoCasale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic R.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Kay","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam H.","family":"Ahmedzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5737\/1181912x234236240","article-title":"Efficacy and side-effect profiles of lactulose, docusate sodium, and sennosides compared to PEG in opioid-induced constipation: a systematic review","volume":"23","author":"Ruston","year":"2013","journal-title":"Can Oncol Nurs J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5055\/jom.2010.0025","article-title":"Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: a systematic literature review","volume":"6","author":"Boswell","year":"2010","journal-title":"J Opioid Manag"},{"key":"B3","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1016\/S0002-9610(01)00782-6","article-title":"Incidence, prevalence, and management of opioid bowel dysfunction","volume":"182","author":"Pappagallo","year":"2001","journal-title":"Am J Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3111\/13696998.2013.851082","article-title":"Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study","volume":"16","author":"Abramowitz","year":"2013","journal-title":"J Med Econ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jpainsymman.2010.02.019","article-title":"The direct and indirect costs of opioid-induced constipation","volume":"40","author":"Hjalte","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0885-3924(02)00424-4","article-title":"Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation","volume":"24","author":"Choi","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","article-title":"Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden","volume":"61","author":"Panchal","year":"2007","journal-title":"Int J Clin Pract"},{"key":"B8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2147\/CEOR.S61602","article-title":"Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review","volume":"6","author":"Coyne","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1111\/pme.12724","article-title":"Opioid-induced constipation among patients with chronic noncancer pain in the United States, Canada, Germany, and the United Kingdom: laxative use, response, and symptom burden over time","volume":"16","author":"Coyne","year":"2015","journal-title":"Pain Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1185\/03007990802584454","article-title":"Fixed-ratio combination oxycodone\/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain","volume":"24","author":"Simpson","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"B12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1517\/14656560902796798","article-title":"Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial","volume":"10","author":"Lowenstein","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","article-title":"Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation","volume":"55","author":"Sloots","year":"2010","journal-title":"Dig Dis Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jpain.2010.11.008","article-title":"Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic, nonmalignant pain: a randomized controlled study","volume":"12","author":"Michna","year":"2011","journal-title":"J Pain"},{"key":"B15","volume-title":"EQ-5D-3L User Guide","author":"Rabin","year":"2011","edition":"4.0 ed"},{"key":"B16","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3111\/13696990903584436","article-title":"Quality of life in relation to constipation among opioid users","volume":"13","author":"Penning-van Beest","year":"2010","journal-title":"J Med Econ"},{"issue":"Suppl 1","key":"B17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1111\/j.1524-4733.2005.00069.x","article-title":"The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue \u2013 the BSW","volume":"8","author":"Pleil","year":"2005","journal-title":"Value Health"},{"key":"B18","first-page":"197","article-title":"Solifenacin: scientific evidence in the treatment of overactive bladder","volume":"63","author":"Santos","year":"2010","journal-title":"Arch Esp Urol"},{"issue":"2","key":"B19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1524-4733.2006.00086.x","article-title":"Performance of the EQ-5D in patients with irritable bowel syndrome","volume":"9","author":"Bushnell","year":"2006","journal-title":"Value Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/ijcp.12718","article-title":"The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use","volume":"69","author":"LoCasale","year":"2015","journal-title":"Int J Clin Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2354.2011.01286.x","article-title":"Laxative management in ambulatory cancer patients on opioid therapy: a prospective, open-label investigation of polyethylene glycol, sodium picosulphate and lactulose","volume":"21","author":"Wirz","year":"2012","journal-title":"Eur J Cancer Care (Engl)"},{"key":"B22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5055\/jom.2009.0014","article-title":"Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey","volume":"5","author":"Bell","year":"2009","journal-title":"J Opioid Manag"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1517\/13543784.2013.819341","article-title":"Pharmacologic treatment of opioid-induced constipation","volume":"22","author":"Wang","year":"2013","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T06:46:05Z","timestamp":1568011565000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2016.00131\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":23,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00131","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]}}}